PY 4/12/23 PY 4/12/23 Ab Initio publishes article in Inhalation Magazine | Fast-tracking inhalation product development using in vitro tools Read More PY 12/23/22 PY 12/23/22 Ab Initio partners on $1m grant to develop innovative COVID vaccine. Read More PY 12/22/22 PY 12/22/22 Novel themoresponsive intranasal technology presented at DDL 2022 Read More PY 11/25/22 PY 11/25/22 Ab Initio Pharma Listed as one of Australia’s Fastest Growing Companies. Read More PY 10/6/22 PY 10/6/22 Ab Inito Pharma Receives GMP Licence from the TGA for Manufacture of Clinical Trial Products Read More PY 10/5/22 PY 10/5/22 Ab Initio Proud to Sponsor RACI Pharmaceutical Science Seminar Series Read More PY 5/30/22 PY 5/30/22 Ab Initio honoured to welcome Lord Mayor of Sydney and esteemed guests. Read More PY 5/30/22 PY 5/30/22 Ab Initio Pharma is a proud sponsor of Innovation Week 2022 Read More PY 5/23/22 PY 5/23/22 Ab Initio talks about product development strategy at ARCS 2022 Read More PY 5/23/22 PY 5/23/22 Ab Initio at ARCS 2022 Read More PY 5/5/22 PY 5/5/22 Ab Initio Pharma and Coleus to give podium on fast-track to phase 1 at RDD2022 Read More PY 5/2/22 PY 5/2/22 Ab Initio Partners with OzUK to offer MDISprint - bench to clinic MDI services Read More PY 5/2/22 PY 5/2/22 Ab Initio CSO, Dr Hui Xin Ong, to give RDD podium on preclinical tools Read More PY 4/26/22 PY 4/26/22 Meet the Ab Initio Team in person at RDD2022 Read More Marcus Chan 4/14/22 Marcus Chan 4/14/22 Meet Team Abinitio Pharma Read More Marcus Chan 12/24/21 Marcus Chan 12/24/21 Merry Christmas Read More PY 12/11/21 PY 12/11/21 Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field Read More PY 11/25/21 PY 11/25/21 Learn how Ab Initio is helping start-ups translate therapeutics to the clinic Read More PY 11/1/21 PY 11/1/21 Ab Initio appoints new COO & Head of Manufacturing Read More PY 10/29/21 PY 10/29/21 Ab Initio CSO interviewed by Cosmos Magazine Read More Newer Posts Older Posts
PY 4/12/23 PY 4/12/23 Ab Initio publishes article in Inhalation Magazine | Fast-tracking inhalation product development using in vitro tools Read More
PY 12/23/22 PY 12/23/22 Ab Initio partners on $1m grant to develop innovative COVID vaccine. Read More
PY 11/25/22 PY 11/25/22 Ab Initio Pharma Listed as one of Australia’s Fastest Growing Companies. Read More
PY 10/6/22 PY 10/6/22 Ab Inito Pharma Receives GMP Licence from the TGA for Manufacture of Clinical Trial Products Read More
PY 10/5/22 PY 10/5/22 Ab Initio Proud to Sponsor RACI Pharmaceutical Science Seminar Series Read More
PY 5/30/22 PY 5/30/22 Ab Initio honoured to welcome Lord Mayor of Sydney and esteemed guests. Read More
PY 5/5/22 PY 5/5/22 Ab Initio Pharma and Coleus to give podium on fast-track to phase 1 at RDD2022 Read More
PY 5/2/22 PY 5/2/22 Ab Initio Partners with OzUK to offer MDISprint - bench to clinic MDI services Read More
PY 12/11/21 PY 12/11/21 Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field Read More
PY 11/25/21 PY 11/25/21 Learn how Ab Initio is helping start-ups translate therapeutics to the clinic Read More
